Clinical Nuclear Medicine

Skip Navigation LinksHome > April 2014 - Volume 39 - Issue 4 > Lymphoma as a Second Malignancy in a Patient With Neuroendoc...
Clinical Nuclear Medicine:
doi: 10.1097/RLU.0b013e31828e98c5
Interesting Images

Lymphoma as a Second Malignancy in a Patient With Neuroendocrine Tumor: Mimicking Dedifferentiation on Dual-Tracer PET/CT With 68Ga-DOTANOC and 18F-FDG

Jain, Sachin MD; Sharma, Punit MD; Dhull, Varun Singh MD; Bal, Chandrasekhar MD; Kumar, Rakesh MD, PhD

Collapse Box


Abstract: Neuroendocrine tumors (NETs) are rare tumors which express somatostatin receptors (SSTRs). We here present a case of a 50-year-old female patient with metastatic bronchial carcinoid. She underwent 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT which suggested a diagnosis of poorly differentiated NET. Biopsy of the lesion, however, revealed a second malignancy in the form of diffuse large B-cell lymphoma. Thus, very rarely, other primary tumors can mimic NETs on dual-tracer PET/CT, and biopsy is advised in doubtful cases.

© 2014 by Lippincott Williams & Wilkins


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.